Dave Muoio

By Dave Muoio 01:44 pmApril 30, 2020
Chronic disease patients relying on DarioHealth's mobile glucose management system will soon have in-app access to medical specialists, thanks to a new telemedicine integration with MediOrbis' MySpecialistMD network. According to an announcement from the companies released yesterday, the virtual services now on offer through the app include primary and acute care; chronic disease management for...
By Dave Muoio 03:34 pmApril 29, 2020
Fitness and sleep-tracking smart-ring-maker Motiv has been acquired by Proxy, a company specializing in digital-identity security. The companies announced the purchase in accompanying blog posts, and did not share the terms of the deal. Proxy CEO Denis Mars wrote that his company has hired "a majority" of Motiv's employees, and will be shifting the focus of Motiv's consumer platform away from...
By Dave Muoio 01:28 pmApril 29, 2020
The shift toward "aging in place" has been fueled by a range of health monitoring technologies – fall-detection pendants, emergency alert systems, fingertip blood pressure monitors, ECG patches and so on. But the senior population has needs and preferences unique from the general population, creating a home health monitoring challenge that can't simply be solved by sending them home with clinical...
By Dave Muoio 03:55 pmApril 28, 2020
UnitedHealth Group's Optum is reportedly in late-stage talks with AbleTo regarding a roughly $470 million acquisition of the virtual behavioral-care company, according to unnamed sources who spoke to CNBC. Optum is already a stakeholder in the New York company, having provided a "significant investment" through its Optum Ventures arm back in January of 2019. At the time, Optum Ventures Principal...
By Dave Muoio 12:48 pmApril 28, 2020
Telehealth and medical messaging startup Medici has tied off a $24 million Series B financing round. Announced yesterday, the raise was driven by the company's existing investors: Barry Sternlicht, from Starwood Capital Group; Kenneth Griffin, from Citadel; Nathan Kirsh, from the Kirsh Group; Howard Jenkins, from Publix; and Tom Meredith, formerly of Dell. WHAT THEY DO While Medici's mobile...
By Dave Muoio 02:55 pmApril 27, 2020
Implementation of either an automated or semi-automated deep learning system for diabetic retinopathy screening could lead to cost savings at the health-system level, according to an economic analysis modeling study recently published in The Lancet Digital Health. Backed by Singapore's Ministry of Health, the investigation looked at data from a national diabetic retinopathy screening program...
By Dave Muoio 01:56 pmApril 24, 2020
Uninsured Massachusetts residents now have 24-7 access to free COVID-19 telehealth visits following a new partnership between Doctor on Demand and the Commonwealth. According to the telehealth provider's announcement, the virtual visits will handle questions an uninsured resident may have about the disease's symptoms. Additionally, it will also support those who have been tagged by Massachusetts...
By Dave Muoio 04:19 pmApril 23, 2020
Telehealth technologies are often cited as opportunities to address disparities in care. Telehealth services that work alongside a school system's health providers are no exception. Getting these programs off the ground – let alone broadly utilized – is no simple feat. "[These school-based interventions] fall into that health disparity use case, and often require multiple stakeholders to think...
By Dave Muoio 01:20 pmApril 23, 2020
XRHealth, a virtual reality health application and services startup, has raised $7 million in a new funding round. The raise comes from Bridges Israel, Flint Capital and 20/20 HealthCare Partners. WHAT THEY DO The startup, which previously went by the name VRHealth, has developed a number of health applications for its VR platform. These offerings include virtual experiences for pain management,...
By Dave Muoio 02:54 pmApril 22, 2020
Real-world evidence platforms Aetion and HealthVerity are playing to their strengths with the joint launch of new tools to support biopharmas and regulators gauging new COVID-19 treatments. The first, called the Real-Time Evidence Platform, is built on an instance of Aetion's platform and focuses on up-to-date usage, safety and effectiveness data. The Real-Time Trend Reporting and Interactive...